Drug Trial Radar · NCT07105111
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Last checked: Nov 20, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Aug 29, 2025
Primary completion
Jun 2028
Study completion Jun 2028
Sponsor
- Lead sponsor
- Neurocrine BiosciencesNeurocrine Biosciences (NBIX)
- Sponsor type
- Industry
- First posted
- Aug 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.
Conditions
- Schizophrenia
- Schizoaffective Disorder
- Bipolar Disorder
- Major Depressive Disorder
- Tardive Dyskinesia
Interventions
ValbenazineDrug
Valbenazine capsules for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in the Abnormal Involuntary Movement Scale (AIMS) Dyskinesia Total Score (AIMS 1-7) at Week 24Time frame: Baseline, Week 24
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Neurocrine Clinical Site
Bryant, Arkansas · Recruiting
Neurocrine Clinical Site
Chino, California · Recruiting
Neurocrine Clinical Site
Fresno, California · Recruiting
Neurocrine Clinical Site
Long Beach, California · Recruiting
Neurocrine Clinical Site
Orange, California · Recruiting
Neurocrine Clinical Site
Redlands, California · Recruiting
Neurocrine Clinical Site
San Diego, California · Recruiting
Neurocrine Clinical Site
Bonita Springs, Florida · Recruiting
Neurocrine Clinical Site
Hialeah, Florida · Recruiting
Neurocrine Clinical Site
Miami, Florida · Recruiting
Neurocrine Clinical Site
Orange City, Florida · Recruiting
Neurocrine Clinical Site
Port Charlotte, Florida · Recruiting
Neurocrine Clinical Site
Tampa, Florida · Recruiting
Neurocrine Clinical Site
Augusta, Georgia · Recruiting
Neurocrine Clinical Site
Naperville, Illinois · Recruiting
Neurocrine Clinical Site
Omaha, Nebraska · Recruiting
Neurocrine Clinical Site
Independence, Ohio · Recruiting
Neurocrine Clinical Site
Austin, Texas · Recruiting
Neurocrine Clinical Site
Richmond, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.